In episode 442, James and Mike welcome back Mike Kolber to discuss all the evidence around biosimilars. The issue is exactly the same one we have had for decades with the question around brand name versus generic medications. Tune in and find out the answer. At the conclusion of this… Read More
… Membership Required You must be a member to access this content. View Membership Levels Already a member? Log in here… Read More
